Quarterly report pursuant to Section 13 or 15(d)

Net Loss per Share Attributable to Common Stock - Antidilutive Securities (Details)

v3.22.1
Net Loss per Share Attributable to Common Stock - Antidilutive Securities (Details) - shares
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Stock option awards    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Common stock equivalents excluded from computation of diluted net loss per share attributable to common stock for the periods presented because their effect would have been anti-dilutive 43,996 60,970
Non-vested restricted stock awards    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Common stock equivalents excluded from computation of diluted net loss per share attributable to common stock for the periods presented because their effect would have been anti-dilutive 693,717 508,784
Common stock warrants    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Common stock equivalents excluded from computation of diluted net loss per share attributable to common stock for the periods presented because their effect would have been anti-dilutive 240,100 240,100